View : 631 Download: 0
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
- Title
- The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
- Authors
- Sato, Yuka; Feig, Daniel, I; Stack, Austin G.; Kang, Duk-Hee; Lanaspa, Miguel A.; Ejaz, A. Ahsan; Sanchez-Lozada, L. Gabriela; Kuwabara, Masanari; Borghi, Claudio; Johnson, Richard J.
- Ewha Authors
- 강덕희
- SCOPUS Author ID
- 강덕희
![scopus](/images/layout/icon2.png)
- Issue Date
- 2019
- Journal Title
- NATURE REVIEWS NEPHROLOGY
- ISSN
- 1759-5061
1759-507X
- Citation
- NATURE REVIEWS NEPHROLOGY vol. 15, no. 12, pp. 767 - 775
- Publisher
- NATURE PUBLISHING GROUP
- Indexed
- SCIE; SCOPUS
![scopus](/images/layout/scopus2.gif)
- Document Type
- Article
- Abstract
- Hyperuricaemia is common among patients with chronic kidney disease (CKD), and increases in severitywith the deterioration of kidney function. Although existing guidelines for CKD management do not recommend testing for or treatment of hyperuricaemia in the absence of a diagnosis of gout or urate nephrolithiasis, an emerging body of evidence supports a direct causal relationship between serum urate levels and the development of CKD. Here, we review randomized clinical trials that have evaluated the effect of urate-lowering therapy (ULT) on the rate of CKD progression. Among trials in which individuals in the control arm experienced progressive deterioration of kidney function (which we define as >= ml/min/1.73 m(2) over the course of the study-typically 6 months to 2 years), treatment with ULT conferred consistent clinical benefits. In contrast, among trials where clinical progression was not observed in the control arm, treatment with ULT was ineffective, but this finding should not be used as an argument against the use of uric acid-lowering therapy. Although additional studies are needed to identify threshold values of serum urate for treatment initiation and to confirm optimal target levels, we believe that sufficient evidence exists to recommend routine measurement of serum urate levels in patients with CKD and consider initiation of ULT among those who are hyperuricaemic with evidence of deteriorating renal function, unless specific contraindications exits.
- DOI
- 10.1038/s41581-019-0174-z
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML